Listed for reference — companies are not ranked in any particular order.
| Market Size 2024 | US$ 572.2 Million |
| Market Size 2031 | US$ 1,274.8 Million |
| CAGR 2025–2031 | 12.1% |
| Segments | By Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Immune Checkpoint Inhibitors) | By Indication (Blood Cancer, Lung Cancer, Breast Cancer) | By End User (Hospital Pharmacies, Retail Pharmacies, Online Stores) |
| Geographies | GCC(United Arab Emirates, Bahrain, Saudi Arabia, Oman, Qatar, Kuwait) |
| Deliverables | Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset |
| Report Code | BMIPUB00033506 |
| Lead Analyst | Krishna Sunthwal — Analyst, Research · View Profile |
Gain actionable insights with 205 pages of in-depth GCC Cancer Targeted Therapy Market, including historical trends, 7-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.